Baker Brothers Life Sciences LP, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 74,109 shares at $75.63 ($5.6M) on 2019-03-12, disclosed to the SEC on 2019-03-14.
Open-market sale of $5.6M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.63 | 938 | $71K | 1.3% |
| 2 | $75.63 | 1,047 | $79K | 1.4% |
| 3 | $75.63 | 1,618 | $122K | 2.2% |
| 4 | $75.63 | 9,384 | $710K | 12.7% |
| 5 | $75.63 | 61,122 | $4.6M | 82.5% |
| Total | $75.63 avg | 74,109 |
| $5.6M |
| 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |